Table 3. Oligonucleotide primers used in this study
Primer |
Designation |
Sequence (5′® 3′) or reference |
Use |
1 |
ospCflank5’+KpnI |
CCTCACTAGGTACCACAGATG |
Construction of the ospC mutant |
2 |
ospCflank3’+NdeI |
GAGGAGTAATTTCATATGAATC |
Construction of the ospC mutant |
3 |
Topo-pCR2.1+BglII-5’ |
GTACCGAGCTCAGATCTACTAG |
Amplification of flaBP-kan |
4 |
Topo+BglII-3’ |
GTGATGGAGATCTGCAGAATTC |
Amplification of flaBP-kan |
5 |
PflgKan.NotI |
9 |
kan probe |
6 |
RC.TKan |
9 |
kan probe |
7 |
pc.18 |
7 |
Sequencing, screening, ospC probe |
8 |
pc.33 |
ATAAGTCCTAGAATAAATTA |
Sequencing, screening, complementation |
9 |
pc.34 |
7 |
Sequencing, screening, complementation |
10 |
pc.38 |
TAATTTGTGCCTCCTTTTTA |
Sequencing, screening |
11 |
pc.41 |
7 |
Sequencing, screening, ospC probe |